BR9813988A - Anticorpos contra vasp fosforilada (fosfoproteìna estimulada por vasodilatador), céulas de hidridoma para a preparação dos mesmos e uso dos mesmos - Google Patents
Anticorpos contra vasp fosforilada (fosfoproteìna estimulada por vasodilatador), céulas de hidridoma para a preparação dos mesmos e uso dos mesmosInfo
- Publication number
- BR9813988A BR9813988A BR9813988-6A BR9813988A BR9813988A BR 9813988 A BR9813988 A BR 9813988A BR 9813988 A BR9813988 A BR 9813988A BR 9813988 A BR9813988 A BR 9813988A
- Authority
- BR
- Brazil
- Prior art keywords
- vasodilator
- preparation
- vasp
- antibodies against
- phosphoprotein
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5064—Endothelial cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/866—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving immunoglobulin or antibody fragment, e.g. fab', fab, fv, fc, heavy chain or light chain
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Organic Chemistry (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Bioinformatics & Computational Biology (AREA)
- Diabetes (AREA)
- Genetics & Genomics (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
Abstract
Patente de Invenção: <B>"ANTICORPOS CONTRA VASP FOSFORILADA (FOSFOPROTEìNA ESTIMULADA POR VASODILATADOR), CéLULAS DE HIBRIDOMA PARA A PREPARAçãO DOS MESMOS E USO DOS MESMOS"<D>. A invenção refere-se a anticorpos contra VASP (fosfoproteína estimulada por vasodilatador), que somente se liga à VASP como um antígeno quando a VASP está presente em forma fosforilada, a células de hibridoma para sua preparação e ao uso dos anticorpos ou dos fragmentos de anticorpo como agentes diagnósticos e/ou agentes terapêuticos.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19749091A DE19749091C1 (de) | 1997-11-07 | 1997-11-07 | Antikörper gegen phosphoryliertes VASP (Vasodilator-Stimuliertes Phosphoprotein), Hybridomzellen zu dessen Herstellung sowie dessen Anwendung |
US7937598P | 1998-03-26 | 1998-03-26 | |
PCT/EP1998/007103 WO1999024473A1 (en) | 1997-11-07 | 1998-11-06 | Antibodies against phosphorylated vasp (vasodilator-stimulated phosphoprotein), hybridoma cells for their preparation, and their use |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9813988A true BR9813988A (pt) | 2000-09-26 |
Family
ID=26041380
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9813988-6A BR9813988A (pt) | 1997-11-07 | 1998-11-06 | Anticorpos contra vasp fosforilada (fosfoproteìna estimulada por vasodilatador), céulas de hidridoma para a preparação dos mesmos e uso dos mesmos |
Country Status (16)
Country | Link |
---|---|
US (2) | US6649421B1 (pt) |
EP (1) | EP1042368B1 (pt) |
JP (1) | JP5031140B2 (pt) |
KR (1) | KR100513418B1 (pt) |
CN (1) | CN1188426C (pt) |
AT (1) | ATE248189T1 (pt) |
AU (1) | AU753557B2 (pt) |
BR (1) | BR9813988A (pt) |
CA (1) | CA2308604C (pt) |
CZ (1) | CZ299889B6 (pt) |
ES (1) | ES2205593T3 (pt) |
HU (1) | HU222411B1 (pt) |
PL (1) | PL195985B1 (pt) |
RU (1) | RU2218178C2 (pt) |
TR (1) | TR200001265T2 (pt) |
WO (1) | WO1999024473A1 (pt) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10029210A1 (de) * | 2000-06-14 | 2002-01-31 | Vasopharm Biotech Gmbh & Co Kg | Testsystem sowie dessen Verwendung |
US6951947B2 (en) * | 2000-07-13 | 2005-10-04 | The Scripps Research Institute | Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparation |
US7176037B2 (en) * | 2000-07-13 | 2007-02-13 | The Scripps Research Institute | Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparation |
EP1182263A1 (en) * | 2000-08-11 | 2002-02-27 | Evotec OAI AG | Process for detecting threonine/serine kinase activity |
US20030162230A1 (en) | 2000-09-27 | 2003-08-28 | Reagan Kevin J. | Method for quantifying phosphokinase activity on proteins |
AU2002221132A1 (en) * | 2000-12-13 | 2002-07-01 | Taisho Pharmaceutical Co. Ltd. | Novel antibody |
EP1735453A2 (en) * | 2004-03-12 | 2006-12-27 | The Scripps Research Institute | Fluorescent signal emitting live cell biosensor molecules and dyes for detection and quantification of protein activities |
CN103102411A (zh) * | 2009-06-11 | 2013-05-15 | 北京华大蛋白质研发中心有限公司 | 一种制备针对糖基化修饰蛋白质的单克隆抗体杂交瘤的方法 |
FR2946756A1 (fr) * | 2009-06-12 | 2010-12-17 | Biocytex | Dosage en sang total d'un biomarqueur intracellulaire appartenant a une voie de signalisation cellulaire- utilisation pour mesurer l'activation d'une population cellulaire determinee |
EP3509613A4 (en) * | 2016-09-07 | 2020-12-02 | Vanderbilt University | VASOACTIVE POLYPEPTIDE FOR THE RELAXATION OF SMOOTH MUSCLES |
CN112730826A (zh) * | 2020-12-23 | 2021-04-30 | 中南大学湘雅三医院 | 一种人磷酸化血管扩张刺激磷蛋白磁微粒化学发光免疫定量检测试剂盒及其检测方法和应用 |
CN113238062B (zh) * | 2021-07-13 | 2021-09-28 | 湖南菲思特精准医疗科技有限公司 | 一种用于人磷酸化血管扩张刺激磷蛋白光激化学发光均相免疫检测试剂盒及其检测方法 |
CN114002440B (zh) * | 2021-12-30 | 2022-04-01 | 湖南菲思特精准医疗科技有限公司 | 一种用于人磷酸化血管扩张刺激蛋白的酶联免疫检测试剂盒及其检测方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2268684T3 (es) | 1992-04-10 | 2007-03-16 | Dana-Farber Cancer Institute, Inc. | Inmunodeteccion de fosfoproteina especifica al estado de activacion. |
-
1998
- 1998-11-06 US US09/530,864 patent/US6649421B1/en not_active Expired - Fee Related
- 1998-11-06 TR TR2000/01265T patent/TR200001265T2/xx unknown
- 1998-11-06 KR KR10-2000-7004901A patent/KR100513418B1/ko not_active IP Right Cessation
- 1998-11-06 CZ CZ20001684A patent/CZ299889B6/cs not_active IP Right Cessation
- 1998-11-06 CN CNB988114542A patent/CN1188426C/zh not_active Expired - Fee Related
- 1998-11-06 RU RU2000114841/14A patent/RU2218178C2/ru not_active IP Right Cessation
- 1998-11-06 PL PL98340465A patent/PL195985B1/pl not_active IP Right Cessation
- 1998-11-06 WO PCT/EP1998/007103 patent/WO1999024473A1/en active IP Right Grant
- 1998-11-06 CA CA002308604A patent/CA2308604C/en not_active Expired - Fee Related
- 1998-11-06 ES ES98963419T patent/ES2205593T3/es not_active Expired - Lifetime
- 1998-11-06 AU AU18712/99A patent/AU753557B2/en not_active Ceased
- 1998-11-06 BR BR9813988-6A patent/BR9813988A/pt not_active IP Right Cessation
- 1998-11-06 HU HU0004099A patent/HU222411B1/hu not_active IP Right Cessation
- 1998-11-06 EP EP98963419A patent/EP1042368B1/en not_active Expired - Lifetime
- 1998-11-06 JP JP2000520481A patent/JP5031140B2/ja not_active Expired - Fee Related
- 1998-11-06 AT AT98963419T patent/ATE248189T1/de not_active IP Right Cessation
-
2003
- 2003-09-22 US US10/664,970 patent/US20040063914A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1042368B1 (en) | 2003-08-27 |
AU1871299A (en) | 1999-05-31 |
CZ20001684A3 (cs) | 2000-11-15 |
KR100513418B1 (ko) | 2005-09-09 |
CA2308604C (en) | 2009-12-15 |
EP1042368A1 (en) | 2000-10-11 |
HU222411B1 (hu) | 2003-06-28 |
US20040063914A1 (en) | 2004-04-01 |
CN1279691A (zh) | 2001-01-10 |
TR200001265T2 (tr) | 2000-09-21 |
RU2218178C2 (ru) | 2003-12-10 |
US6649421B1 (en) | 2003-11-18 |
HUP0004099A3 (en) | 2002-01-28 |
CN1188426C (zh) | 2005-02-09 |
PL340465A1 (en) | 2001-02-12 |
CA2308604A1 (en) | 1999-05-20 |
AU753557B2 (en) | 2002-10-24 |
HUP0004099A1 (en) | 2001-03-28 |
KR20010031830A (ko) | 2001-04-16 |
WO1999024473A1 (en) | 1999-05-20 |
PL195985B1 (pl) | 2007-11-30 |
JP5031140B2 (ja) | 2012-09-19 |
CZ299889B6 (cs) | 2008-12-29 |
ATE248189T1 (de) | 2003-09-15 |
ES2205593T3 (es) | 2004-05-01 |
JP2001522865A (ja) | 2001-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9813988A (pt) | Anticorpos contra vasp fosforilada (fosfoproteìna estimulada por vasodilatador), céulas de hidridoma para a preparação dos mesmos e uso dos mesmos | |
ES2293973T3 (es) | Anticuerpos anti-ccr2 humanizados y metodos de uso de los mismos. | |
BRPI0513959A (pt) | anticorpos dirigidos contra o peptìdeo beta-amilóide, suas composições farmacêuticas, kit e métodos de fabricação dos mesmos | |
BR9106394A (pt) | Anticorpos anti-icam-1 quimericos humanizados,processos de preparacao e uso | |
BR9710968A (pt) | Antìgenos de célula b humana; reagentes correlatos | |
CR8231A (es) | Anticuerpos rg1 y uso de los mismos | |
ATE324119T1 (de) | Verwendung von saccharid-konjugaten | |
BR9712278A (pt) | Processos e composições para imunomodulação | |
BRPI0412879A (pt) | conjugado citotóxico especìfico do antìgeno ca6 e métodos de seu uso | |
TR200200781T1 (tr) | Birlikte uyaran bir sinyal transdüksiyon molekülü olan ailime karşı insan monoklonal antikoru ve bunun farmasötik kullanımı | |
BR9912975A (pt) | Composto e composições para liberação de agentes ativos, método para sua obtenção e seu uso | |
TR200002938T2 (tr) | Mikrobakteri tüberküloz antijenlerinin füzyon proteinleri ve bunların kullanımı | |
PT724456E (pt) | Anticorpos contra cd4 | |
PT1315520E (pt) | Utilizacao de anticorpos trifuncionais biespecificos e triespecificos para tratamento de ascites malignas | |
NO982062L (no) | Humaniserte antistoff mot humant gp39, sammensetninger inneholdende dette, samt terapeutisk anvendelse derav | |
MA30353B1 (fr) | Anticorps se liant à la protéine tyrosine phosphatase bêta humaine (hptpbêta) et utilisations correspondantes. | |
AU6832398A (en) | Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof | |
BRPI0413495A (pt) | reagentes de peptìdeos especìficos para prìons e seus usos | |
BR0116686A (pt) | Anticorpos anti-cd28 silenciados e uso dos mesmos | |
AU2002223462A1 (en) | Use of cd28-specific monoclonal antibodies for stimulating blood cells that lackcd28 | |
AU9363398A (en) | Hepatitis c receptor protein cd81 | |
WO1999046379A3 (en) | Human receptor proteins; related reagents and methods | |
TR200102034T2 (tr) | Anti kanser aşılaması için antikorların kullanılması | |
WO2001057219A3 (en) | Mammalian interleukin-1-delta and -epsilon. their use in therapeutic and diagnostic methods | |
AU6008800A (en) | Preparation of spheres for diagnostic tests |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A,7A,8A E 9A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1910 DE 14/08/2007. |